Treatment of diabetic ketoacidosis

摘要

There is disclosed the use of β-lactone alkylene carboxylic acids and derivatives thereof, which are known compounds, for the use of treating diabetic ketoacidosis. The compounds are administered orally or parenterally and compositions containing the β-lactone alkylene carboxylic acid compounds as the active ingredient are also disclosed.